Last update: Oct. 27, 2014

Acamprosate Calcium

Low Risk for breastfeeding

Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.

GABA-Acid Agonist use to treat alcohol addicted patients.

On latest update no published data about breastfeeding were found.

Pharmacokinetic data indicates that drug excretion into breast milk in significant amount can occur but oral absorption would be minimal with the possibility of mild side effects.


Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.


Acamprosate Calcium belongs to this group or family:


Main tradenames from several countries containing Acamprosate Calcium in its composition:


Variable Value Unit
Oral Bioavail. 10 %
Molecular weight 401 daltons
Protein Binding 0 %
VD 1 - 1,6 l/Kg
T1/2 20 - 33 hours


  1. Acamprosate Data Sheet (FDA) 2010 Full text (in our servers)
  2. Acamprosato Ficha técnica 2008 Full text (in our servers)

Total visits


Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at

e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana from Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM